HIMS Hims Hers Health Inc
Company Analysis
Latest News
Labs AI Launches, Stock Drops: Can Hims & Hers Convince Wall Street That AI Is Worth Paying For?
Shares of Hims & Hers Health fell 4% to $25.79 on a day the company unveiled a splashy new product, raising a pointed question: is the telehealth firm's AI...
🔴 HIMS is trading 4% down today despite the launch of its Labs AI care agent
HIMS is trading at $25.79 (-4%) as the stock underperforms the broader technology sector despite the debut of its new AI-powered care platform. • The company...
🔴 HIMS Drops 4% Despite Launch of New "Labs AI" Platform
Hims & Hers (HIMS) is trading down over 4% to $25.79, underperforming a broadly stronger technology market. The decline occurs on the same day the company...
🔴 HIMS falls 4%, extending losses after FDA proposes new rules on compounded GLP-1 drugs
Hims & Hers Health (HIMS) is trading down ~4% to $26.17, continuing its decline following recent news of proposed regulatory changes by the U.S. Food and Drug...
Hims & Hers Faces Lawsuits Over Data Security and Privacy Failures
Hims & Hers Health faces multiple class-action lawsuits alleging data security and privacy failures. The legal actions claim the company mishandled data...
Hims & Hers Discloses Support Data Breach, Medical Records Remain Secure
Hims & Hers Health, Inc. confirmed a data breach involving a third-party customer service platform. The company detected suspicious activity on February 5,...